HomeAI · summaries
Storia in 2 fonti
Celltrion secures FDA's 1st interchangeable status for Rituximab biosimilar - The Korea Times
A key cancer treatment developed by Celltrion has become the first rituximab biosimilar to receive interchangeability status from the United States...
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
koreaherald.com
Celltrion's Truxima wins FDA interchangeability designation
Celltrion said Wednesday that its blood cancer treatment Truxima received interchangeability designation from the US Food and Drug Administration, becoming the
- ·
koreatimes.co.kr
Celltrion secures FDA's 1st interchangeable status for Rituximab biosimilar - The Korea Times
A key cancer treatment developed by Celltrion has become the first rituximab biosimilar to receive interchangeability status from the United States...